Diabetes Pill Rejected By Panel | ThirdAge
Links shared publicly online about this topic.
- 130total visits
Diabetes Pill Rejected By Panel | ThirdAge
View full resource at thirdage.com
Tags: Liver, Diabetes, Diet and Nutrition, Drug, FDA, AstraZeneca, Bristol-Myers Squibb
Most Recently Shared on July 21, 2011 at 7:54 pm By:
Diabetes Pill Rejected By Panel http://bit.ly/op9mZT
Weight loss pill Qnexa wins panel vote and awaits approval
news-medical.net — “The drug was rejected in a 10-6 vote the first time it came before a Food and Drug Administration (FDA) advisory panel, in 2010, due to safety concerns. However when the medication returned for another review in February, the advisory committee gave it near-unanimous approval (20-2). Because the FDA often follows the advisory panel's advice, Qnexa is likely to get FDA approval, probably by mid-April.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 11:08 pm By:
Diet News: Weight loss pill Qnexa wins panel vote and awaits approval: The drug was rejected in a 10-6 vote the ... http://t.co/rGbONdEq
New Type Of Diabetes Pill “Likely Dead,” Says Goldman Sachs - Matthew Herper - The Medicine Show - Forbes
blogs.forbes.com — “Goldman Sachs pharmaceuticals analyst Jami Rubin said in a note to investors that the rejection of dapagliflozin, a new diabetes drug from Bristol-Myers Squibb and AstraZeneca, by a panel of advisers to the Food and Drug Administration probably means that safety and efficacy concerns will either limit the use of [...]” View full resource at blogs.forbes.com
Most Recently Shared on July 20, 2011 at 6:43 pm By:
New Type Of Diabetes Pill "Likely Dead," Says Goldman Sachs: Goldman Sachs pharmaceuticals analyst Jami Rubin... http://onforb.es/psCcmz
PharmaLive: FDA Advisory Committee Makes Recommendation on Investigational Compound Dapagliflozin
pharmalive.com — “PharmaLive: FDA Advisory Committee Makes Recommendation on Investigational Compound Dapagliflozin” View full resource at pharmalive.com
Most Recently Shared on July 20, 2011 at 6:02 pm By:
PharmaLive Pharma and Health News
Daily Advantage - FDA Panel Rejects Bristol/Astra Diabetes Pill - http://tinyurl.com/3chmck3
New Type Of Diabetes Pill “Likely Dead,” Says Goldman Sachs - Matthew Herper - The Medicine Show - Forbes
blogs.forbes.com — “Goldman Sachs pharmaceuticals analyst Jami Rubin said in a note to investors that the rejection of dapagliflozin, a new diabetes drug from Bristol-Myers Squibb and AstraZeneca, by a panel of advisers to the Food and Drug Administration probably means that safety and efficacy concerns will either limit the use of [...]” View full resource at blogs.forbes.com
Most Recently Shared on July 20, 2011 at 1:55 pm By:
Drugs and Devices OW OW Health
New Type Of Diabetes Pill "Likely Dead," Says Goldman Sachs: Is this the end of the road for a promisin... http://onforb.es/qD4jJq #drug
Panel rejects AstraZeneca, Bristol diabetes pill | Reuters
reuters.com — “SILVER SPRING, Maryland (Reuters) - U.S. advisers rejected a new type of diabetes pill from AstraZeneca and Bristol-Myers Squibb over concerns about liver and cancer risks.A Food and Drug Administration” View full resource at reuters.com
Most Recently Shared on July 19, 2011 at 9:29 pm By:
Ben Hirschler Health Communicator
US panel rejects #AstraZeneca, Bristol diabetes pill - will AZ have better luck with FDA verdict on #Brilinta tomorrow? http://t.co/bWzmElF
Panel rejects AstraZeneca, Bristol diabetes pill | Reuters
reuters.com — “SILVER SPRING, Maryland (Reuters) - U.S. advisers rejected a new type of diabetes pill from AstraZeneca and Bristol-Myers Squibb over concerns about liver and cancer risks.A Food and Drug Administration” View full resource at reuters.com
Most Recently Shared on July 19, 2011 at 8:53 pm By:
Hisham Rana, MD Doctor and Physician
News: FDA advisory panel rejects AstraZeneca, Bristol diabetes pill #dapagliflozin http://reut.rs/p2kAmN - #health #pharma
FDA Advisory Panel rejects AstraZeneca, Bristol diabetes pill - Yahoo! News - Jack's posterous
pharmagossip.posterous.com — “FDA Advisory Panel rejects AstraZeneca, Bristol diabetes pill - Yahoo! News - Jack's posterous” View full resource at pharmagossip.posterous.com
Most Recently Shared on July 19, 2011 at 8:45 pm By:
Jack Friday - PharmaGossip Health Blog
FDA Advisory Panel rejects AstraZeneca, Bristol diabetes pill - Yahoo! News http://post.ly/2YCRU
Lorcaserin Weight Loss Pill Rejected by FDA Panel | ThirdAge
thirdage.com — “Lorcaserin was highly expected to be a new, safer weight loss pill. Those hopes were dashed when the Food and Drug Administration's panel of experts voted against approving the drug. Read more at ThirdAge.com.” View full resource at thirdage.com
Most Recently Shared on September 17, 2010 at 12:59 am By:
Weight loss pill Lorcaserin was rejected by the expert FDA panel. http://dld.bz/vUDH
Advertisement
